AV

Assanparampil Varughese Mathew

Active Director Director DIN 09371654
DIN 09371654 First appointment Oct 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Assanparampil Varughese Mathew

Data last updated:

Assanparampil Varughese Mathew is a Director at Samaria Medicity Private Limited (since 2021). The company operates in Healthcare.

DIN 09371654
Primary Designation Director
Industry Healthcare
First Appointment 23 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Samaria Medicity Private Limited U85190KL2021PTC071791
Director23 Oct 20212021Active

Board colleagues of Assanparampil Varughese Mathew

Directorship timeline

Open interactive timeline →
Samaria Medicity Private Limited
Premium access

Shareholding and investment profile for Assanparampil Varughese Mathew

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Assanparampil Varughese Mathew

Assanparampil Varughese Mathew currently holds 1 directorship: Samaria Medicity Private Limited (Director, since 23 Oct 2021).

Assanparampil Varughese Mathew was first appointed on 23 Oct 2021 as Director at Samaria Medicity Private Limited.

The current boards of Assanparampil Varughese Mathew's companies include Abraham Kalamannil Joseph (Samaria Medicity Private Limited), Christy Thomas (Samaria Medicity Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available